Presentation is loading. Please wait.

Presentation is loading. Please wait.

Individualized therapy for persistent asthma in young children

Published byMarylou Smith Modified over 6 years ago

Similar presentations

Presentation on theme: "Individualized therapy for persistent asthma in young children"— Presentation transcript:

1 Individualized therapy for persistent asthma in young children
Anne M. Fitzpatrick, PhD, Daniel J. Jackson, MD, David T. Mauger, PhD, Susan J. Boehmer, MA, Wanda Phipatanakul, MD, MS, William J. Sheehan, MD, James N. Moy, MD, Ian M. Paul, MD, MSc, Leonard B. Bacharier, MD, Michael D. Cabana, MD, Ronina Covar, MD, Fernando Holguin, MD, Robert F. Lemanske, MD, Fernando D. Martinez, MD, Jacqueline A. Pongracic, MD, Avraham Beigelman, MD, Sachin N. Baxi, MD, Mindy Benson, MSN, PNP, Kathryn Blake, PharmD, James F. Chmiel, MD, Cori L. Daines, MD, Michael O. Daines, MD, Jonathan M. Gaffin, MD, Deborah Ann Gentile, MD, W. Adam Gower, MD, Elliot Israel, MD, Harsha Vardhan Kumar, MD, Jason E. Lang, MD, MPH, Stephen C. Lazarus, MD, John J. Lima, PharmD, Ngoc Ly, MD, Jyothi Marbin, MD, Wayne Morgan, MD, Ross E. Myers, MD, J. Tod Olin, MD, Stephen P. Peters, MD, PhD, Hengameh H. Raissy, PharmD, Rachel G. Robison, MD, Kristie Ross, MD, Christine A. Sorkness, PharmD, Shannon M. Thyne, MD, Stanley J. Szefler, MD  Journal of Allergy and Clinical Immunology  Volume 138, Issue 6, Pages e12 (December 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Study diagram and procedures. Blood, Blood collection; Diary, electronic diary distribution and data review; Height, height measurement; Urine, urine collection. +, Procedure was performed. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Flow chart depicting the number of participants who enrolled in the study, underwent randomization, completed the study, and provided analyzable data for analysis. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 A, Probability of each asthma treatment being the best of the 3. Gray shading depicts participants who did not have a differential response. B and C, Percentage of ACDs (Fig 2, B) and probability of an exacerbation (Fig 2, C). Box plots represent the median value, 25th to 75th percentiles (shading), and 5th to 95th percentiles (whiskers). Outliers are shown as triangles. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Probability of best response based on aeroallergen sensitization (A), previous exacerbation (B), sex (C), eosinophil count of 300/μL or greater (D), and combination of sensitization and eosinophil counts (E). P values correspond to the test of interaction between the predictor and treatment and indicate whether the pattern of treatment response differs according to subgroup. Sample sizes correspond to participants with evaluable data (n = 230). Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Cumulative probability of an exacerbation requiring systemic corticosteroids for all participants with evaluable data (n = 230) stratified by aeroallergen sensitization (A), blood eosinophil counts of 300/μL or greater (B), and combinations of aeroallergen sensitization and blood eosinophil counts (C). Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig E1 A, Patterns of treatment differences according to daily ICS versus LTRA or placebo during the run-in period. B, Patterns of treatment differences according to daily ICS versus LTRA or as-needed ICS receipt during the first treatment period. C, Patterns of treatment differences during each of the 3 treatment periods. Models included allergic sensitization, history of exacerbations, and sex as covariates. Best response probabilities and P values for each analysis were obtained from rank-ordered logistic regression with bootstrap CIs. P values correspond to the test of interaction between predictor and treatment in the logistic regression model and indicate whether the pattern of treatment response differs according to subgroup. P values are post hoc and not adjusted for multiple testing. Sample sizes correspond to all participants with evaluable data (n = 230). Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Fig E2 Patterns of treatment differences are shown according to serum ECP concentration (A), sensitization to pet aeroallergens (dog, cat, or both; B), mAPI status (C), serum IgE level (D), and urinary LTE4 concentration (E). Greater superiority of daily ICS was associated with an ECP concentration of 10 μg/L or greater and sensitization to a pet aeroallergen. mAPI status, serum IgE level, and urinary LTE4 concentration were not significant predictors. Probabilities and P values for each analysis were obtained from rank-ordered logistic regression with bootstrap CIs. P values correspond to the test of interaction between predictor and treatment in the logistic regression model and indicate whether the pattern of treatment response differs according to subgroup. Models included allergic sensitization, history of exacerbations, and sex as covariates, with the exception of the pet sensitization model, which was only adjusted for exacerbations and sex. P values for exploratory predictors are post hoc and not adjusted for multiple testing. Sample sizes correspond to all participants with evaluable data (n = 230, except where otherwise noted because of missing samples). Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Fig E3 A and B, Percentage of ACDs during the course of the trial for all participants with evaluable data (n = 230), with nondifferential responders on the far left followed by differential responders on the right stratified by sensitization to at least 1 aeroallergen (A), blood eosinophil counts of 300/mL or greater (B), and combinations of sensitization and eosinophil counts (C). Box plot horizontal lines represent the median value, shaded boxes represent the 25th to 75th percentile, and whiskers represent the 5th to 95th percentile. Outliers are shown as triangles and represent data values from individual participants. Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Journal of Allergy and Clinical Immunology 2016 138, 1608-1618
Journal of Allergy and Clinical Immunology  , e12DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Individualized therapy for persistent asthma in young children"

Similar presentations

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations  Stephen J. Teach, MD, MPH, Michelle.
Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.

Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.
Journal of Allergy and Clinical Immunology

Journal of Allergy and Clinical Immunology
Vitamin D over the first decade and susceptibility to childhood allergy and asthma  Elysia M. Hollams, PhD, Shu Mei Teo, PhD, Merci Kusel, MBBS, PhD, Barbara.

Vitamin D over the first decade and susceptibility to childhood allergy and asthma  Elysia M. Hollams, PhD, Shu Mei Teo, PhD, Merci Kusel, MBBS, PhD, Barbara.
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Susan L. Limb, MD, Kathryn C. Brown, MD, Robert A. Wood, MD, Robert A

Susan L. Limb, MD, Kathryn C. Brown, MD, Robert A. Wood, MD, Robert A
Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.
Jonathan Malka, MD, David T

Jonathan Malka, MD, David T
SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial  Stephen.
Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,

Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: Role of predictors in the setting of high adherence  Rebecca S. Gruchalla,
Theresa W. Guilbert, MD, David T. Mauger, PhD, David B

Theresa W. Guilbert, MD, David T. Mauger, PhD, David B
Alalia Berry, MD, William W. Busse, MD 

Alalia Berry, MD, William W. Busse, MD 
Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD 
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,

A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,
Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J

Stephen P. Peters, MD, PhD, Eugene R. Bleecker, MD, Susan J
Asthma phenotypes in inner-city children

Asthma phenotypes in inner-city children
Individualized therapy for persistent asthma in young children

Individualized therapy for persistent asthma in young children
Ann-Marie M. Schoos, MD, PhD, Jacob D

Ann-Marie M. Schoos, MD, PhD, Jacob D
Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial  Christine A. Sorkness,

Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: The Pediatric Asthma Controller Trial  Christine A. Sorkness,
Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.

Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children  Susan V. Lynch, PhD, Robert A. Wood, MD, Homer.

Similar presentations

Ads by Google